The PD-1/PD-L1 interaction suppresses the activity and proliferation of cytotoxic tumor-infiltrating lymphocytes (TILs) and favors the immunosuppressive effects of regulatory T-lymphocytes. The gene discussed is CD274; the disease is neoplasm.